No results for ‘’
Bilcare Ltd
NSE: BSE: 526853
₹92.92
(3.44%)
Sun, 20 Sept 2026, 02:40 pm
Market Cap (in Cr)219.54
PE Ratio28.19
Dividend0
Process Industries
Containers/Packaging
24.5KCompany History
1987
- The company was promoted as Bhandari Paper Products (P) Ltd.
- The company took over the assets and liabilities of New India Packaging Company.
1991
- The company stopped supplying laminated paper containers to the Ministry of Defence.
1994
- The company changed its name to Bhandari Industries Private Limited and converted into a Public Limited Company.
- A fresh certificate of incorporation was obtained from the Registrar of Companies, Maharashtra, Bombay.
2003
- The company issued and allotted bonus shares in the ratio of 2 equity shares for every 1 equity share held.
- The company approved the allotment of 65,65,200 equity shares of Rs 10/- as fully paid bonus shares.
2005
- Bilcare inaugurated a first-of-its-kind 'Clinical Services' facility in India.
2009
- Dr. Arthur J Carty and Prof. Dr. Bhojraj Suresh were appointed as Directors on the Board of Directors of the Company.
2010
- Bilcare successfully executed non-ClonableID technology worldwide.
- Bilcare AG completed the acquisition of INEOS' Global Films Business.
2012
- Bilcare signed a definitive agreement with United Drug plc.
- United Drug plc completed the USD 61 million acquisition of Bilcare's US and UK-based Global Clinical Supplies businesses.
2014
- CS Pawan G. Chandak was appointed as Director of the company.
- The company received the Frost & Sullivan Global 2014 Award.
- The company received the CII Industrial Innovation Award.
2015
- Bilcare was recognized as Admired 100 Brands & Leaders of Asia-2014-15 by VWP World Brands.
2016
- Bilcare GCS received the ABP News Healthcare award 2015 for best Clinical Trial Services.